Progyny: At This Price, Secular Tailwinds Are Too Compelling To Ignore

Progyny (NASDAQ:PGNY) has not received much love lately after reporting a topline miss in their Q1 2024 call on May 9th, with the stock dropping around 15%. Management attributed the miss to a decline in utilization rates that coincided with an Alabama's supreme court ruling that embryos should have the same legal rights as persons. The utilization decline was more pronounced in red states, according to management. Yet, the long-term prospects remain stable in my opinion. Two secular tailwinds present signi ...